The European Union has been criticized for the slow pace of its Covid-19 vaccine rollout: from the delayed approval of shots, to supply issues and more recently, the suspension of the AstraZeneca vaccine. CNBC's Silvia Amaro looks at the challenges of vaccinating millions of people across the 27 member states.